Literature DB >> 7525272

The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

J R Mesters1, L A Zeef, R Hilgenfeld, J M de Graaf, B Kraal, L Bosch.   

Abstract

A structural and functional understanding of resistance to the antibiotic kirromycin in Escherichia coli has been sought in order to shed new light on the functioning of the bacterial elongation factor Tu (EF-Tu), in particular its ability to act as a molecular switch. The mutant EF-Tu species G316D, A375T, A375V and Q124K, isolated by M13mp phage-mediated targeted mutagenesis, were studied. In this order the mutant EF-Tu species showed increasing resistance to the antibiotic as measured by poly(U)-directed poly(Phe) synthesis and intrinsic GTPase activities. The K'd values for kirromycin binding to mutant EF-Tu.GTP and EF-Tu.GDP increased in the same order. All mutation sites cluster in the interface of domains 1 and 3 of EF-Tu.GTP, not in that of EF-Tu.GDP. Evidence is presented that kirromycin binds to this interface of wild-type EF-Tu.GTP, thereby jamming the conformational switch of EF-Tu upon GTP hydrolysis. We conclude that the mutations result in two separate mechanisms of resistance to kirromycin. The first inhibits access of the antibiotic to its binding site on EF-Tu.GTP. A second mechanism exists on the ribosome, when mutant EF-Tu species release kirromycin and polypeptide chain elongation continues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525272      PMCID: PMC395428          DOI: 10.1002/j.1460-2075.1994.tb06815.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts.

Authors:  O Fasano; W Bruns; J B Crechet; G Sander; A Parmeggiani
Journal:  Eur J Biochem       Date:  1978-09-01

2.  Identification of the part of kirromycin structure that acts on elongation factor Tu.

Authors:  G Chinali
Journal:  FEBS Lett       Date:  1981-08-17       Impact factor: 4.124

3.  A kirromycin resistant elongation factor EF-Tu from Escherichia coli contains a threonine instead of an alanine residue in position 375.

Authors:  F J Duisterwinkel; J M de Graaf; B Kraal; L Bosch
Journal:  FEBS Lett       Date:  1981-08-17       Impact factor: 4.124

4.  Spectroscopic studies of the nucleotide binding site of elongation factor Tu from Escherichia coli. An approach to characterizing the elementary steps of the elongation cycle of protein biosynthesis.

Authors:  J F Eccleston
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

5.  A 1H NMR study of the Escherichia coli elongation-factor Tu with guanine nucleotides and the antibiotic kirromycin.

Authors:  R Römer; W Block; A Pingoud; H Wolf
Journal:  FEBS Lett       Date:  1981-04-20       Impact factor: 4.124

6.  The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP.

Authors:  A Pingoud; W Block; A Wittinghofer; H Wolf; E Fischer
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

7.  The nucleotide sequence of the cloned tufA gene of Escherichia coli.

Authors:  T Yokota; H Sugisaki; M Takanami; Y Kaziro
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

8.  Molecular properties of two mutant species of the elongation factor Tu.

Authors:  P H Van der Meide; F J Duisterwinkel; J M De Graaf; B Kraal; L Bosch; J Douglass; T Blumenthal
Journal:  Eur J Biochem       Date:  1981-06

9.  Two elongation factors from the extremely halophilic archaebacterium Halobacterium cutirubrum. Assay systems and purification at high salt concentrations.

Authors:  M Kessel; F Klink
Journal:  Eur J Biochem       Date:  1981-03

10.  Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevis.

Authors:  W Wörner; H Wolf
Journal:  FEBS Lett       Date:  1982-09-20       Impact factor: 4.124

View more
  12 in total

1.  Cryo-EM reveals an active role for aminoacyl-tRNA in the accommodation process.

Authors:  Mikel Valle; Jayati Sengupta; Neil K Swami; Robert A Grassucci; Nils Burkhardt; Knud H Nierhaus; Rajendra K Agrawal; Joachim Frank
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

2.  Identification of novel inhibitors of bacterial translation elongation factors.

Authors:  Maithri M K Jayasekera; Keysha Onheiber; John Keith; Hariharan Venkatesan; Alejandro Santillan; Emily M Stocking; Liu Tang; Jennifer Miller; Leslie Gomez; Brooke Rhead; Tavner Delcamp; Shaoming Huang; Ronald Wolin; Ekaterina V Bobkova; Karen Joy Shaw
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  Throwing a spanner in the works: antibiotics and the translation apparatus.

Authors:  C M Spahn; C D Prescott
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

4.  The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.

Authors:  E Vorstenbosch; T Pape; M V Rodnina; B Kraal; W Wintermeyer
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.

Authors:  E J Arts; M E Quiñones-Mateu; J L Albright; J P Marois; C Hough; Z Gu; M A Wainberg
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 6.  Translational regulation by modifications of the elongation factor Tu.

Authors:  B Kraal; C Lippmann; C Kleanthous
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

7.  Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.

Authors:  Lian N Olsthoorn-Tieleman; Robert-Jan T S Palstra; Gilles P van Wezel; Mervyn J Bibb; Cornelis W A Pleij
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

8.  Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.

Authors:  R Cetin; I M Krab; P H Anborgh; R H Cool; T Watanabe; T Sugiyama; K Izaki; A Parmeggiani
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

9.  The unique tuf2 gene from the kirromycin producer Streptomyces ramocissimus encodes a minor and kirromycin-sensitive elongation factor Tu.

Authors:  Lian N Olsthoorn-Tieleman; Sylvia E J Fischer; Barend Kraal
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

10.  Codon-dependent conformational change of elongation factor Tu preceding GTP hydrolysis on the ribosome.

Authors:  M V Rodnina; R Fricke; L Kuhn; W Wintermeyer
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.